家族史对结直肠癌相对与绝对风险的影响:系统综述与荟萃分析
该系统综述与荟萃分析检索MEDLINE、EMBASE和Cochrane至2018年7月,纳入42项病例对照研究和20项队列研究,评估家族史对结直肠癌风险的影响。结果显示一级亲属患结直肠癌的相对风险低于既往预期,尤其基于队列研究;风险估计受患病人数和诊断年龄影响,高危人群可考虑强化结肠镜监测。
要点
- 1名一级亲属患结直肠癌的汇总RR在病例对照研究中为1.92,队列研究为1.37。
- 2名及以上一级亲属患结直肠癌的RR在病例对照研究中为2.81,队列研究为2.40。
- 一级亲属50岁前诊断结直肠癌时RR更高,病例对照研究为3.57,队列研究为3.26。
核心结论
- 一级亲属患结直肠癌的相对风险低于既往预期,尤其基于队列研究。
- 风险估计受患结直肠癌亲属数量和诊断年龄影响。
- 高危人群可考虑强化结肠镜监测策略。
研究设计与样本
- 系统检索MEDLINE、EMBASE和Cochrane从建库至2018年7月。
- 纳入42项病例对照研究和20项队列研究。
- 采用随机效应模型计算汇总相对风险,并用寿命表转换为绝对风险。
主要发现
- 1名一级亲属患结直肠癌的RR:病例对照研究1.92(95%CI 1.53-2.41),队列研究1.37(95%CI 0.76-2.46)。
- 2名及以上一级亲属患结直肠癌的RR:病例对照研究2.81(95%CI 1.73-4.55),队列研究2.40(95%CI 1.76-3.28)。
- 一级亲属50岁前诊断结直肠癌的RR:病例对照研究3.57(95%CI 1.07-11.85),队列研究3.26(95%CI 2.82-3.77)。
- 西欧人群85岁时结直肠癌累积绝对风险:1名一级亲属4.8%(95%CI 2.7%-8.3%),2名及以上8.2%(95%CI 6.1%-10.9%),一级亲属50岁前诊断11%(95%CI 9.5%-12.4%)。
临床怎么用
- 对有一级亲属结直肠癌家族史者,应结合亲属数量和诊断年龄评估风险。
- 高危人群(如2名及以上一级亲属或一级亲属50岁前诊断)可考虑强化结肠镜监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Guidelines recommend that individuals with familial colorectal cancer undergo colonoscopy surveillance instead of average-risk screening. However, these recommendations vary widely. To substantiate appropriate surveillance strategies, precise and valid evidence-based risk estimates are needed for individuals with a family history of colorectal cancer (CRC). METHODS: We systematically searched MEDLINE, EMBASE, and Cochrane from inception to July 2018 for case-control and cohort studies investigating the effect of family history on CRC risk. We calculated summary estimates of pooled relative risks (RRs) using a random-effects model. Life tables were created to convert RR estimates into absolute risk estimates. RESULTS: We screened 4417 articles and identified 42 eligible case-control and 20 cohort studies. In case-control studies, the RR for CRC in patients with 1 first-degree relative (FDR with CRC) was 1.92 (95% CI, 1.53-2.41) and 1.37 (95% CI, 0.76-2.46) for cohort studies. For individuals with 2 or more FDRs with CRC, the RR was 2.81 in case-control studies (95% CI, 1.73-4.55) and 2.40 in cohort studies (95% CI, 1.76-3.28). For individuals having a FDR diagnosed with CRC at an age younger than 50 years, the RR for CRC in their FDRs was 3.57 in case-control studies (95% CI, 1.07-11.85) and 3.26 in cohort studies (95% CI, 2.82-3.77). The cumulative absolute risks for CRC at 85 years in Western Europe were 4.8% for persons with 1 FDR with CRC (95% CI, 2.7%-8.3%), 8.2% for individuals with 2 or more FDRs (95% CI, 6.1%-10.9%), and 11% for persons with a FDR diagnosed with CRC at an age younger than 50 years (95% CI, 9.5%-12.4%). CONCLUSIONS: In this systematic review and meta-analysis, we found that the RR of CRC among FDRs is lower than previously expected, especially based on cohort studies. Risk estimates are affected by the number of relatives with CRC and their age at diagnosis. Intensified colonoscopy surveillance strategies could be considered for high-risk groups. PROSPERO trial identification no: CRD42018103058.
引用
- Roos VH, Mangas-Sanjuan C, Rodriguez-Girondo M, et al. Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2019. PMID: 31525516. doi:10.1016/j.cgh.2019.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。